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Abstract: Reduced periodontal support, deriving from chronic inflammatory conditions, such as
periodontitis, is one of the main causes of tooth loss. The use of dental implants for the
replacement of missing teeth has attracted growing interest as a standard procedure in clinical
practice. However, adequate bone volume and soft tissue augmentation at the site of the implant
are important prerequisites for successful implant positioning as well as proper functional and
aesthetic reconstruction of patients. Three-dimensional (3D) scaffolds have greatly contributed to
solve most of the challenges that traditional solutions (i.e., autografts, allografts and xenografts)
posed. Nevertheless, mimicking the complex architecture and functionality of the periodontal
tissue represents still a great challenge. In this study, a porous poly(ε-caprolactone) (PCL) and
Sr-doped nano hydroxyapatite (Sr-nHA) with a multi-layer structure was produced via a single-step
additive manufacturing (AM) process, as a potential strategy for hard periodontal tissue regeneration.
Physicochemical characterization was conducted in order to evaluate the overall scaffold architecture,
topography, as well as porosity with respect to the original CAD model. Furthermore, compressive
tests were performed to assess the mechanical properties of the resulting multi-layer structure. Finally,
in vitro biological performance, in terms of biocompatibility and osteogenic potential, was evaluated
by using human osteosarcoma cells. The manufacturing route used in this work revealed a highly
versatile method to fabricate 3D multi-layer scaffolds with porosity levels as well as mechanical
properties within the range of dentoalveolar bone tissue. Moreover, the single step process allowed the
achievement of an excellent integrity among the different layers of the scaffold. In vitro tests suggested
the promising role of the ceramic phase within the polymeric matrix towards bone mineralization
processes. Overall, the results of this study demonstrate that the approach undertaken may serve as a
platform for future advances in 3D multi-layer and patient-specific strategies that may better address
complex periodontal tissue defects.
Keywords: polymer-based composites; multi-layer scaffold; single-step additive manufacturing;
periodontal tissue engineering
1. Introduction
Oral diseases represent a significant health and economic problem, affecting about 3.5 billion
people worldwide [1]. This burden is expected to increase as a direct consequence of the aging global
population, of which more than 20% will be older than 65 by 2050 [2,3]. Among the different oral
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conditions, tooth loss has been recognized as one of the most common [4]. This can be the result of
trauma, oral cavities, cancer and periodontal diseases, which comprise of periodontitis and gingivitis.
Periodontitis is a chronic inflammatory condition, characterized by the damage of the periodontium,
which include the hard (i.e., alveolar bone and cementum) and soft (i.e., gingiva and periodontal
ligament) tissues that surround the teeth. In case of severe periodontitis, reduced periodontal support
can lead to tooth movement and eventually tooth loss [5].
As such, the use of dental implants for the replacement of missing teeth has attracted growing
interest as a standard procedure. However, to ensure successful implant placement, the presence of
adequate vertical and horizontal bone as well as soft tissue is fundamental [6]. Bone tissue augmentation
is a procedure of paramount importance to provide mechanical stability and aesthetic functionality,
before dental implant placement into patients. Augmentation can be achieved through the use of
different bone grafting materials (including autografts, allografts and xenografts) and with properties
that vary from space maintenance, blood clot stabilization and scaffolding, by providing a temporary
template to support tissue regeneration [7,8].
Even though bone grafting materials have been a long-standing strategy in the regeneration of
dentoalveolar bone tissue, they suffer from several disadvantages that include poor processability,
possibility of infections and immune reactions, high costs and long surgery times [9].
Tissue engineering approaches that leverage biomaterials as well as manufacturing technologies
have opened new doors for dentoalveolar reconstruction through the introduction of 3D scaffolds [10].
In order to support hard periodontal tissue regeneration, it has been established that a 3D scaffold
should be biocompatible and bioactive to allow bone tissue bonding [11], it should have a total porosity
similar to human cancellous bone (30–90%) and be characterized by an interconnected network of
pores, which should be in the range between 150 and 500 µm, in order to facilitate vascularization
and new tissue formation without compromising its overall mechanical stability [12]. Regarding the
mechanical performance, the scaffold should possess adequate mechanical strength until full tissue
formation is achieved. Moreover, and in order to guarantee its function, the scaffold should degrade at
a rate that has to match the bone remodeling process, which in the case of an alveolar bone within
5–6 months has been considered optimal [8,13].
At present, the most widely applied biomaterials for bone scaffolds’ production include synthetic
polymers (such as polycaprolactone (PCL), polylactic acid (PLA), polyglycolic acid (PGA) and
polylactic-co-glycolic acid (PLGA)) [14–16], as well as bioceramics (such as β-tricalcium phosphate
(β-TCP), hydroxyapatite (HA) and its doped alternatives) [17–20]. Polymeric materials have
showed great promise as 3D substitutes for bone tissues, particularly for their widely demonstrated
biocompatibility, biodegradability and easy processability [21,22]; whereas bioceramics have been
mainly investigated for their similarity to the inorganic phase of native bone tissue, and thus for
their positive outcomes towards osteointegration, osteoinduction and osteoconduction [23]. However,
given the composite characteristics of native human bone, the promising combination of polymers
and ceramics, and where each phase contributes with its own strengths to the final biomaterial-based
solution, has been recognized by several research works [16,24–26].
Within the periodontal tissue engineering field, the benefits in using HA and its doped
formulations to promote osteoblast-like cell adhesion, differentiation and proliferation, leading to
faster osteointegration and enhanced bone tissue formation has been demonstrated by different
research groups [27–30]. Additionally, the ability of nHA to promote human periodontal ligament cell
proliferation as well as its therapeutic effect on periodontal epithelium have also been established [28,31].
Particularly, strontium (Sr) is a promising trace element that, by replacing the calcium in the HA lattice,
has shown great ability in supporting new bone formation by inducing osteoblast and preventing
osteoclast activity [32,33]. In a recent study from the authors it has been demonstrated that Sr-containing
composite scaffolds showed greater levels of mineralization and osteogenic potential in comparison to
bare PCL and pure HA-based composites [34]. Furthermore, Tsai et al. reported on the fabrication of PCL
membranes containing strontium-doped nano hydroxyapatite (Sr-nHA) nanofibers and their potential
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for guided bone regeneration applications [35]. However, periodontal regeneration involves a set of
complex tissues and structures in and around the tooth; hence, a biomaterial-based approach should
involve the use of a functionally graded scaffold, where the architecture as well as the composition
of each comportment match the fine organization of the tissue that needs to be regenerated [36–38].
In 2015, Rasperini et al. fabricated the first patient-specific additively biomanufactured scaffold for
periodontal bone regeneration in humans, by using a PCL/HA composite produced via selective laser
sintering technology [39]. Even though Rasperini et al. established the potential of the additively
manufactured scaffold for the treatment of a large periodontal bone defects, the long-term results,
particularly the limited bone regeneration, suggested the need for incorporating scaffold design
imperatives (i.e., larger and interconnected pores network). In the past decade, novel AM technologies,
i.e., multi-extrusion 3D printing, have been explored in the whole field of tissue engineering, showing
great promise as a valuable strategy for the development of multi-layer scaffolds [40,41]. However,
in clinical dentistry this approach is still in its beginning and yet to be marginally investigated.
In this work, a multi-layer 3D composite scaffold, based on a novel architectural design and
established biomaterial formulations was developed as a strategy for the regeneration of hard
periodontal tissue. The multi-layer cell-free scaffold was designed (Figure 1) and manufactured via
a multi-material extrusion 3D printing. This approach offers the promising opportunity to fabricate
complex tissue engineering scaffolds through the ability to co-print multiple biomaterials within
the same construct by using independent dispensing systems [42]. Particularly, with respect to
traditional fused deposition modeling, multi-extrusion 3D printing is a single-step approach, which is
advantageous for the production of scaffolds able to mimic native tissue organization with high
precision and reproducibility, starting from a computer aided design (CAD) model and thus allowing
the development of patient-specific solutions [43,44].
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Based on the outcomes of recent studies, the multi-layer scaffold was produced through a
composite formulation, including a biodegradable polymeric matrix of PCL and a bioactive reinforcing
phase of Sr-doped nano hydroxyapatite (Sr-nHA). The overall region-specific structure includes
three compartments: a bottom one (C1) with high Sr-nHA content (20% w/w) coded as 20Sr-nHA to
interface the alveolar bone tissue, an upper compartment (C3) with a lower ceramic content (10%
w/w) coded as 10Sr-nHA to interface the cementum and an intermediate microporous one (C2) to
guide the regeneration of the tissue between the alveolar bone and the cementum. Manufacturing
process reproducibility, with respect to the original CAD model, as well as scaffold physicochemical
and mechanical properties were assessed. Subsequently, in vitro biological performance, in terms
of biocompatibility, alkaline phosphatase (ALP) activity and mineralization potential up to 28 days,
was evaluated. In this regard, human bone osteosarcoma cells were used since they have been widely
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investigated for the initial in vitro appraisal of candidate biomaterials for bone tissue engineering
applications [45–47].
2. Materials and Methods
2.1. Design and Manufacturing of the Multi-Layer Scaffold
The latest experts’ opinion evidenced that further optimization and refinement of the current
periodontal biomaterial-based strategies are needed in order to functionally combine spatial, mechanical
and biological benefits [44,48]. To support the still unmet demand for hybrid and multiphasic materials
in dental practice, in this work a multi-layer composite scaffold intended to guide the regeneration of the
hard periodontal tissue at the interface between the alveolar bone and the cementum was developed.
Cylindrical scaffolds with 7 mm diameter and 6 mm height were designed by using Solid EdgeTM
3D software, and then imported onto a dedicated platform (BioplotterRP 3.0 Software, EnvisionTEC,
Gladbeck, Germany) in order to produce the slicing of the solid element. The entire architecture (see
Table 1 for details) was made up of fourteen layers using a laydown pattern of 0/90◦ to create a porous
structure. Each layer of the structure was printed continuously, following the geometry edge of the
designed cylinder with a single extruded filament. Based on the recommendations and findings of
recent studies [8,12,39], in order to increase pore interconnectivity (with pore dimensions between 150
and 500 µm) without compromising the mechanical properties, and allow a better in vitro performance,
an offset distance equal to half the distance between strands was used (see Figure 1). Specifically,
for the first 9 layers of the scaffold, intended to mimic the alveolar bone, the distance between two
adjoining strands was set as 0.8 mm. In the C2 compartment of the scaffold, the distance between the
strands was reduced from 0.8 to 0.7 mm, this in order to create a microporous structure intended to
mimic the interface between the alveolar bone and the cementum; whereas the last five layers (C3)
were produced using the same design of the first compartment and a lower ceramic content (10% w/w)
within the PCL matrix. The same multi-layer architecture and inner pattern was followed to produce
the bare PCL scaffold, which was used as a control.
Table 1. 3D scaffold composition, design parameters and architecture.
Scaffold Code Architecture Strand Distance Material Composition
PCL
C3: layer 10 to 14 0.8 mm
PCL
C2: layer 7 to 9 0.7 mm
PCL/Sr-nHA
PCL/10Sr-nHA (10% w/w)
C1: layer 1 to 6 0.8 mm
PCL/20Sr-nHA (20% w/w)
PCL/20Sr-nHA (20% w/w)
Powdered poly-ε-caprolactone (PCL) with a relative molecular weight of 50 kDa and a particle
size <600 µm was purchased from Polyscience Europe (Hirschberg, Germany). Sr-nHA, with strontium
substitution at 20% molar weight, was produced as previously described [34] and supplied by the
Biomaterials Innovation and Development Centre of Riga Technical University (Riga, Latvia).
The manufacturing of the scaffold was performed by using a 3D-Bioplotter system (EnvisionTEC,
Gladbeck, Germany). Briefly, Sr-nHA was homogeneously mixed with the polymeric phase in two
different concentrations (10:90 and 20:80 w/w respectively) using a mortar and pestle, then left overnight
on a mechanical shaker (Stuart Scientific, Stone, UK), and ultimately 4 g of each of the powder
mixtures were placed into stainless-steel cartridges (22G blunt tip needle, 0.4mm internal diameter)
for processing.
Printing conditions (pressure, speed, pre- and post-flow, wait time) for the different formulations
were then optimized and fixed as reported in Table 2.
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Table 2. 3D printing parameters.
Temperature
(◦C)
Pressure
(bar)
Speed
(mm/s)
Pre-Flow
(s)
Post-Flow
(s)
Wait Time
(s)
PCL 130 5.3 0.7 0.45 0.1 10
PCL/10Sr-nHA 130 6.3 0.5 0.75 0.2 10
PCL/20Sr-nHA 140 6.5 0.4 0.75 0.2 10
2.2. Scaffold Physicochemical Characterization
In order to assess the chemical composition of the materials before and after the manufacturing
process, the raw powders as well as the extruded filaments were analyzed through attenuated total
reflectance Fourier transform infrared spectroscopy (ATR-FTIR). A Nicolet iS5 (Thermo Scientific, Stone,
UK) equipped with an iD5 ATR diamond crystal window was used for the analyses. All the spectra
were measured in the spectral range between 500 and 4000 cm−1. Thermogravimetric analysis (TGA)
was performed in order to investigate the thermal characteristics as well as the composition of the
printed composite materials. Particularly, TGA was useful to assess the actual Sr-nHA content within
the polymeric matrix before and after the manufacturing process. A TGA2 METTLER TOLEDO™with
a resolution of 1 µg, weighing accuracy of 0.005% and weighing precision of 0.0025% was used to carry
out the analyses. The extruded samples were tested in a range starting at room temperature (25 ◦C)
and up to 800 ◦C, using a heating rate of 10 ◦C/min. Three samples of approximately 10 mg were tested
for each formulation (PCL, PCL/10Sr-nHA and PCL/20Sr-nHA). The materials’ weight losses were
measured and then normalized to the initial mass weight for each sample. The dedicated software
STARe™ was used as an interface with the device to process the obtained information.
Moreover, the strands’ dimension and the top surface morphology of the 3D printed scaffolds were
evaluated by a scanning electron microscope (SEM, Hitachi FE-SEM SU5000, Hitachi, Ltd., Tokyo, Japan).
Prior to the image acquisition, the printed scaffolds were gold coated, using a manual sputter system
(Quorum Technologies, Lewes, UK), and subsequently fixed on aluminum stubs. The coated samples
were placed on the SEM stage and analyzed using a voltage of 7 kV and a working distance around
6 mm. All the images were collected through the equipment’s software. In addition, the topology and
the internal architecture of the scaffolds were analyzed via microcomputed tomography (microCT).
A Bruker Skyscan 1275 (Bruker, Kontich, Belgium), equipped with the Hamamatsu L11871 source and
3 MP active pixel CMOS (complementary metal oxide semiconductor) flat panel detector was used.
The scanning was conducted under 30 kV and 250 µA in the microCT with an acquisition time of 49 ms
and a pixel resolution of 10 µm. Reconstruction of the scans was performed using the NRecon software
(Bruker, Kontich, Belgium), whereas qualitative visualization of the 3D architecture and the different
phases of the composite material were performed and acquired through the CTvox software (Bruker,
Kontich, Belgium).
3D scaffolds porosity (P) was calculated theoretically by using the following formula:
P (%) = 1− pid
2
1
4d2d3
× 100 (1)
in which, d1 represents the diameter of the strand, d2 the distance between strands and d3 the height of
the printed layer. Moreover, the porosity of the 3D printed scaffolds was calculated experimentally
through the CTan software (Bruker, Kontich, Belgium), and where the actual dimensions of d1, d2 and
d3 were derived from the 2D sections of the microCT acquisitions. Subsequently, the software ImageJ
was employed to obtain the measurements of the desired parameters, calculated as the average of three
different samples.
In order to assess the mechanical performance of the multi-layer scaffolds, compression tests were
carried out using an Instron 5500S testing machine (Instron, High Wycombe, UK), equipped with a
500 N load cell. The specimens (7 mm diameter and 6 mm height, n = 5) were initially subjected to a 2
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N preload and then compressed across the longitudinal direction with a constant cross-head speed of
0.5 mm/min up to a deformation of 50% or until the safety range of the load cell, set at 490 N, was
reached. The data collected were analyzed using Matlab and the Young’s modulus was calculated
from the slope of the linear region of the stress–strain curve.
2.3. Scaffold Biological Characterization
2.3.1. Cell Culture and Scaffold Seeding
Human bone osteosarcoma epithelial cells (U2OS Line, Thermo Fisher Scientific, UK) were
cultured in McCoy’s growth medium (modified with l-glutamine, phenol-red and sodium bicarbonate)
containing 10% of fetal bovine serum heat-inactivated (FBS-HI, Gibco) and 1% of the antibiotic agent
(Penicillin-Streptomycin, Gibco). The medium was changed every second day. Cells at passages
7 were used for subsequent experiments. Before cell seeding, 3D scaffold compartments were
sterilized following a two-step approach. Firstly, IPA (isopropyl alcohol, Honeywell, UK) was used
to completely submerge the scaffolds for 15 min; after that, samples were washed three times with
PBS (phosphate-buffered saline, Sigma Aldrich, Dorset, UK). In addition to this, 3D scaffolds were
transferred into a 48 well plate and placed under a UV lamp (BioSan DNA/ RNA UV cleaner, λ = 253.7
nm) for 20 min. Samples were finally seeded by placing 5 µL of cell suspension (100,000 cells/mL)
on their surface, and then incubated under standard conditions (37 ◦C, 5% CO2, 95% air, humidified
environment); after 3 h 950 µL of fresh media was added into every well in order to reach a final
volume of 1 mL.
2.3.2. Cell Metabolic Activity, Morphology and Proliferation Test
MTT colorimetric assay was used to assess cell metabolic activity. After 1, 3 and 7 days post-seeding,
100 µL of the MTT solution (Sigma-Aldrich, 4% w/v), prepared following the supplier’s instructions,
was added in each well (10% of total well volume) and samples (n = 5) were left in incubation for 3 h at
37 ◦C, 5% CO2 with protection from light exposure and in order to induce MTT reduction into purple
formazan crystals. The solution was than replaced with 800 µL of IPA (Honeywell, UK) solvent and
samples were left on a mechanical shaker at room temperature for 30 min. Subsequently, 200 µL of
medium were dispensed into a 96 well plate and placed into a microplate reader (Sunrise™, Tecan,
UK). The absorbance of each well was spectrophotometrically measured at a wavelength of 562 nm
and measurements were taken in triplicate. Cell adhesion on the substrates was then evaluated after 3
and 7 days post-seeding.
Scaffold compartments were firstly washed with PBS; then, 1 mL of PFA (paraformaldehyde,
Sigma-Aldrich, 4% in PBS, pH 7.4) was added into each well and left for 8 min at room temperature.
Subsequently, each sample was washed three times with PBS before adding 800 µL of DAPI solution,
used to completely cover the scaffolds’ volume. The DAPI working solution (300 nM) was prepared
through a dilution of the DAPI (Thermo Fisher, Stone, UK) stock solution (5 mg/mL, 14.3 mM) in PBS.
After 10 min of incubation in the dark and at room temperature, samples were washed twice with PBS
and stored by adding 1–2 drops of the mounting medium (Sigma-Aldrich, Dorset, UK). An upright
fluorescence microscope (Nikon ECLIPSE 80i) with a filter in the range between 350 and 450 nm was
used for imaging. Different images were captured at two different magnifications using 20× and 10×
objectives. In addition, the cells’ morphology was assessed via SEM analysis. After removing the culture
media, samples were washed with sterile PBS and then chemically fixed with 2.5% glutaraldehyde
(Sigma-Aldrich, Dorset, UK). Then, the fixing reagent was removed and the samples were further
rinsed with PBS followed by post-fixation with 1% osmium tetroxide (Sigma-Aldrich, Dorset, UK)
for 10 min. After rinsing with deionized water, the scaffolds were subsequently dehydrated using
graded ethanol of 25%, 50%, 75%, 90% and 100%, then immersed into hexamethyldisilazane (HMDS,
Sigma-Aldrich, Dorset, UK) and left for drying overnight before SEM investigation (20 A current and
5 kV voltage).
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2.3.3. Osteogenic Potential
To assess the scaffold osteogenic potential, alkaline phosphatase (ALP) activity (as an early
osteogenic differentiation marker) was measured by using the ALP assay kit (Sigma-Aldrich, Dorset,
UK) up to 28 days. After removing the media, samples were washed three times with PBS and
fixed in 4% PFA. Subsequently, cells were washed with 0.1% PBS/Tween20® solution and alkalinized
with water/0.1M Tris solution (Sigma-Aldrich, Dorset, UK). After 25 min of incubation the alkaline
solution was replaced with 1 mL of ALP solution (pNPP, Sigma-Aldrich, Dorset, UK) and samples
were incubated for 30 min in the dark at room temperature. Of solution 100 µL was then taken from
each well and placed in a clear-bottom 96-well plate to quantify the ALP activity. The reading was
performed with a spectrometer (Tecan Scan™, Männedorf, Switzerland) at 405 nm. The results are
based on the values obtained from a standard 8 points calibration curve, calculated by placing different
known concentrations (from 200 to 0 ng/mL) of 0.1 M Tris/ALP into a 96-well plate. Additionally,
ALP enzyme concentration was normalized over the total amount of proteins obtained through the
BCA assay (ThermoFisher, Pierce™ BCA Protein Assay Kit, UK), in order to relate the measure to
the effective number of cells in each sample. Following the procedure of the BCA kit, cells were
washed three times with 1 mL of sterile PBS, then 1 mL of Tryple Express (Gibco TrypLE Thermofisher
scientific, Scotland, UK)/1% Triton X-100 (Sigma Aldrich, St. Louis, MO, USA) was added and the plate
was placed in incubation (37 ◦C) for 30 min. Afterwards, cell suspension was collected into sterile
microtubes that were stored at −85 ◦C for 8 min. The suspensions were than microcentrifuged at
14,000 RFC at 4 ◦C for 10 min producing a separation between the solid cell bodies and the supernatant
containing the released proteins. Aliquots of the supernatant of each sample (10 µL per well) were
transferred into a 96 well plate and 200 µL of the BCA working reagent, previously prepared, were
added as well. The plate was covered in foil and agitated for 5 min on a plate rotator (40 rpm) before
being incubated for 30 min at 37 ◦C. The reading was performed with a spectrometer (Tecan Sunrise™,
Theale, UK) at 562 nm. The results, obtained from a 9-points standard BCA curve, were calculated
from different known concentrations between 2000 and 0 µg/mL. The dilutions were prepared from the
BCA standard stock provided at a concentration of 2 µg/mL, whereas the diluent was the same used to
dilute the proteins into cells suspension. Both tests (ALP/BCA assays) were performed in triplicate
after 7, 14, 21 and 28 days.
2.3.4. Calcium Detection
After removing the culture media, 3D scaffolds were fixed in 4% PFA and washed in PBS twice.
Afterwards, samples were stained with 1 mL of Alizarin red solution (Sigma Aldrich, Dorset, UK),
prepared in deionized water (2% w/v). Following an incubation time of 30 min at room temperature,
the alizarin red solution was removed and scaffolds were washed multiple times and dried overnight
at 60 ◦C in a 5% CO2 atmosphere. Samples were analyzed through optical microscopy using an
Olympus™ CKX53 Inverted Microscope equipped with a 5× magnification objective. The experiment
was performed at day 0, 7, 14 and 28.
2.4. Statistical Analysis
All the experiments were performed at least in triplicate. The results are reported as
mean ± standard deviation (STD). Differences between groups were determined using a two-way
ANOVA followed by a Dunnett’s test of significance, with a significance level ofα = 5% (p values < 0.05).
3. Results and Discussion
3.1. Scaffold Composition, Design and Production
Single unit multi-layer composite scaffolds were produced in this work through a solvent free and
single step manufacturing process. The composite scaffolds were developed by using a PCL polymeric
matrix mainly for its good printability, biodegradability and for being an FDA approved biomaterial [49].
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In relation to the ceramic phase, previous studies on Sr-containing biomaterials in various forms
indicated that even small amounts of Sr (0.1 wt%) can enhance the osteoconductive properties of
calcium phosphate, have a positive effect on bone mineralization, elevate the mechanical property of
bone tissue and have crucial effects by inducing collagen type I synthesis [50–53]. Additionally, it has
been reported that Sr can act via the calcium-sensing receptor and promote the transductions of the
mitogen-activated protein kinase signaling. Thus, the substitution of calcium with strontium in the HA
structure can lead to a ceramic material with improved bioactivity and osteogenic properties [32,54].
Furthermore, based on the promising findings of a recent study, according to which the use of Sr-nHA
enhanced the osteogenic potential and mineralization of human mesenchymal stromal cells, in this work
Sr-nHA (2.46 wt%) was selected as reinforcing phase for the PCL polymeric matrix [34]. The content
of the nanosized ceramic phase was chosen to decrease along the structure going from the bottom
(alveolar bone, 20% w/w) to the top (cementum, 10% w/w).
In relation to the scaffold design, a novel architecture was developed to mimic the multi-phasic
architecture of hard periodontal tissue. After an initial optimization of the printing process, multi-layer
scaffolds were manufactured according to the parameters reported in Table 2.
No major differences were recorded in terms of printing temperature between PCL and
PCL/10Sr-nHA, whereas the increased content of Sr-nHA powder (above 10 wt%) required further
optimization of the printing conditions. Particularly, higher printing temperature, but still below
the degradation temperature of the PCL matrix, and pressure were needed to guarantee a consistent
and defect-free extrusion process of the composite formulation. As reported by previous studies,
this behavior might be due to the polymer acting as nucleation site for the ceramic phase, and thus
requiring different processing conditions [55,56].
3.2. Characterization of Multi-Layered Scaffolds
ATR-FTIR was performed in order to assess the chemical composition, in terms of functional
groups, of both precursors in the form of powders and extruded materials, thus before and after the
manufacturing process. In Figure 2A PCL spectra shows the characteristic bands of this polymer.
Specifically, the C–H stretching (2943 and 2865 cm−1), the C=O carbonyl group at 1720 cm−1, and the
CH2 deformation band at 1165–1468 cm−1, the backbone C–O and C–C stretching in the crystalline phase
at 1293 cm−1 and the C–O–C symmetric and asymmetric band at 1239 cm−1, 1164 cm−1, 1107 cm−1 and
1047 cm−1 [57]. In relation to the composite powders (PCL/10Sr-nHA and PCL/20Sr-nHA), the Sr-nHA
hexagonal crystalline structure produced intensive IR absorption bands at 560 and 600 cm−1 and at
1041 cm−1, deriving from the O–H and PO3−4 groups [34,35].
As is clearly visible in Figure 2B, the presence of the polymeric as well as the ceramic phase was
still evident in the extruded composite formulations, suggesting that the 3D manufacturing process
did not affect the chemical composition of the printed materials, and proving the efficacy of the solvent
free mechanical mixing.
The extruded materials were then analyzed through TGA analysis (see Figure 3). PCL shows
a complete degradation with a reaction that started at around 300 ◦C and ended at 550 ◦C, with a
maximum decomposition peak at 490.2 ◦C. Both composite samples displayed a similar weight
loss profile, evidencing that the Sr-nHA presence did not affect the composite materials’ thermal
stability [58]. Moreover, the residue of ceramic content for PCL/10Sr-nHA and PCL/20Sr-nHA was
8.75 ± 0.94 wt% and 17.3 ± 3.45 wt% respectively, proving to be within the wt% of the inorganic
component of the as designed formulations, and further demonstrating how the hot melt extrusion
approach did not affect the biomaterials’ thermal behavior.
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The morphology and topology of the 3D printed scaffolds were then assessed both qualitatively
and quantitatively. According to the SEM analysis, printed scaffolds (see Figure 4) showed well-aligned
and parallel filaments, both in the horizontal and perpendicular planes, with an average strand
diameter equal to 461 ± 10 µm, 455 ± 7 µm and 433 ± 13 µm for PCL, PCL/10Sr-nHA and PCL/20Sr-nHA
respectively. These values coherently matched the theoretical parameters of the CAD design, indicating
the high reproducibility of the manufacturing process. Additionally, from the high magnification
SEM images (see Figure 4D–F), it is possible to observe how the presence of the ceramic phase affects
the strand surface at the microscopic level. In accordance to the findings reported by Bruyas et al.
and Huang et al., by increasing the ceramic content the composite filaments’ surface appeared less
smooth than the bare PCL and with more pronounced micropores, whose formation might be due to
the collision of ceramic particles with PCL crystalline regions growing during solidification [58,59].
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In addition, a non-destructive characterization technique was used to investigate the 3D
printed multi-layer scaffold architecture as well as the inner geometry. According to the microCT
reconstructions (Figure 5), the optimized printing conditions led to the production of 3D scaffolds
with continuous filaments, deposited in a layer-by-layer fashion, along with an interconnected
structure within each layer (see Figure 5A–C). Towards the development of tissue-like scaffolds,
interconnectivity has been demonstrated to be an essential requirement, crucial to aid cell growth,
migration and proliferation [60,61]. Furthermore, according to the 3D reconstructions of the cross
section, the multi-layer scaffold showed the homogeneous distribution of the ceramic phase within the
polymeric matrix. Additionally, it can be observed (see Figure 5D) how individual layers had a distinct
architecture seamlessly integrated. Particularly, the C2 layers resulted in being strongly connected with
the upper C3 and bottom C1 layers. This is of great importance to ensure the mechanical integration at
the junctions and prevent any possibility of delamination after implantation [62,63], yet allowing the
cross-talk within the overall microenvironment.
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Regarding the printed scaffolds’ porosity, whose data are reported in Table 3, it can be observed
that the experimental porosity values, derived from the microCT analysis, for both PCL and multi-layer
PCL/Sr-nHA scaffolds were consistent with those calculated using the theoretical formula and within
the range of dentoalveolar bone [12]. Additionally, similarly to the finding reported by Bittner et al.,
no differences were observed following the incorporation of the ceramic phase on the scaffold total
porosity in comparison to the pure PCL samples [42].
Table 3. Theoretical and experimental porosity values of the overall 3D scaffolds (PCL and PCL/Sr-nHA)
and for each compartment (C1, C2 and C3) within the overall structure.
CODE
Total Porosity (%)—Overall Total Porosity (%)—Compartments
Theoretical Experimental Theoretical Experimental
PCL
C3: 41.56
C2: 32.50
C1: 41.56
37.36 ± 0.99 C3: 41.56
C3: 40.2 ± 1.5
C2: 30.3 ± 1.2
C2: 32.50
C1: 36.6 ± 1.3
PCL/Sr-nHA 39.02 ± 0.51
C3: 43.6 ± 2.5
C1: 41.56
C2: 31.6 ± 1.7
C1: 42.5 ± 0.9
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Considering prior literature, it has been demonstrated that the mechanical properties of human
bone depend greatly on patient age, activity and location in the body. As result, the compressive
modulus values have been found to vary in a range rather being ascribed to a single value [64]. In the
case of low load-bearing applications like alveolar bone, the scaffold stability and the appropriate 3D
shape for functional and aesthetic reason have been considered more important than high mechanical
properties [65]. The multi-layer PCL/Sr-nHA scaffolds produced in this work were then characterized via
uniaxial compression tests. The composite samples displayed values of Young’s modulus comparable
with those of pure PCL (Figure 6A), indicating that the inclusion of the ceramic phase up to 20%
(w/w) broadly affected the scaffold elastic modulus in compression. As demonstrated by the findings
reported in other studies, this outcome might be the consequence of the mechanical mixing rather than
chemical blending of the two phases, in which the polymer act as a matrix, surrounding the ceramic
nanoparticles [34,66,67]. However, the poor adhesion at the interface between different compartments
has been one of the main issues of previous multi-layer approaches, and where the combination of
different materials within the same structure was considered. As can be observed from Figure 6B,
different multi-layer samples displayed stress–strain curves with a very similar trend. This result
can be considered a clear indication of the scaffolds ability to maintain structural integrity under
compressive loadings, and hence indicating the suitability of the manufacturing approach to fabricate
3D scaffolds with reproducible mechanical performance.
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3.3. In Vitro Biological Performance
The biological performance of the different material formulations within the multi-layer 3D scaffold
was then assessed in vitro by using the human osteosarcoma U2OS cell line. Viability, attachment,
osteogenic and mineralization potential were evaluated. As shown by the MTT colorimetric assay
results, reported in Figure 7, the absorbance values increased with time, evidencing a progressive
growth of the U2OS cells’ metabolic activity after 7 days in culture. By comparing the composite samples
tested, no significant differences were recorded within the groups and with respect to PCL-based
scaffolds at both day 1 and 7. Only at day 3, the metabolic activity of the specimens with greater
Sr-nHA content was significantly higher with respect to the other two. However, being PCL and FDA
approved biomaterial it can be stated that both scaffold compositions proposed in our study sustain
U2OS cell proliferation.
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Figure 7. Absorbance values of the MTT assay evaluated up to 7 days for PCL, PCL/10Sr-nHA and
PCL/20Sr-nHA scaffolds in culture with U2OS cells (data are presented as mean ± standard deviation;
n = 3, p < 0.05 (*)).
These results ere confir ed by a DAPI cytofluorometric assay (see Figure 8).
U2OS proliferation on the 3D additively manufactured scaffolds was investigated for 7 days. Despite
the PCL autofluorescence in the same range of re cti it , this as ay enabled U2OS nuclei
visualization and adhesion on both scaffolds’ urface and within the inner architecture [68,69].Polymers 2020, 12, x 14 of 21 
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Figure 8. DAPI staining of U2OS cells seeded on PCL (A,D,G), PCL/10Sr-nHA (B,E,H) and
PCL/20Sr-nHA (C,F,I) after 1 a d 7 days in culture; ((A–F) scale bar = 400 µm; (G–I) scale bar = 200
µm).
U2OS proliferated considerably well on all the scaffolds over time, with a higher cell density on
the composite-b s d scaffold surface after 7 days i culture. Addition lly, it has be n observed that
cells were slightly more concentrated i the intersection area between two orthogonal stra ds on all
sample types. T is result suggests t at, in accordance to previous studies, the shifted design pattern as
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well as its interconnected porosity allowed U2OS migration into the sample’s depth, leading to cell
growth into the internal 3D structure [14,70].
In order to assess the cell–material interaction, morphological investigation via SEM analysis was
conducted on the additively manufactured samples 14 days after seeding. From the low magnification
images (Figure 9A–F)) cell distribution and attachment can be observed. Cell growth was oriented
across the strand direction, and with a surface coverage that resulted in being more pronounced on
the sample with higher ceramic content (Figure 9C–F) in comparison to the control (Figure 9A–D).
Moreover, as shown in the higher magnification images, cell–cell contact and filopodia formation
was established particularly on the composite-based samples (Figure 9H,I), whereas on the PCL
scaffold surface cells displayed a more rounded shape and the filopodia were almost indiscernible.
This outcome was mainly ascribed to the scaffold composition, since it is widely reported as the
essential role of nHA and Sr-containing nHA to promote attachment, proliferation and osteoblastic
differentiation [34,50,53]. Furthermore, the actual roughness of the as printed composite scaffolds’
(see Figure 4E–F) could be identified as another reason determining the positive cell–substrate
interaction informed in Figure 9 [71–73].Polymers 2020, 12, x 15 of 21 
 
 
Figure 9. SEM micrographs of U2OS cells seeded on PCL (A,D,G), PCL/10Sr-nHA (B,E,H) and 
PCL/20Sr-nHA (C,F,I) after 14 days in culture; ((A–C) scale bar = 200 μm; (D–F) scale bar = 40 μm; 
(G–I) scale bar = 8 μm). 
Mineralization potential was then assessed qualitatively by Alizarin red assay. Alizarin red, an 
anthraquinone dye, has significant binding affinity to deposited calcium. Hence, it is normally used 
to verify the presence of matrix mineralization, and as such, it is considered an early stage marker for 
osteogenesis [76]. In our study, Alizarin red assay enabled us to prove the extent of mineralization 
activity supported by 3D printed scaffolds. The stain color in all groups became darker by increasing 
time intervals, suggesting that more calcium was deposited onto the scaffolds over time (Figure 10B). 
There was a detectable difference in both the red staining color and presence of inorganic calcium 
components over the surface of composite-based samples; the inorganic deposits resulted in being 
bigger in size and more uniformly distributed in comparison to the control. In agreement with recent 
literature, this observation demonstrates that greater mineralization was generated by the Sr-
containing scaffolds with respect to the monophasic PCL, indicating both PCL/10Sr-nHA and 
PCL/20Sr-nHA samples as a promising platform for U2OS growth and osteogenesis [34,53,77]. 
Figure 9. SEM micrographs of U2OS cells seeded on PCL (A,D,G), PCL/10Sr-nHA (B,E,H) and
PCL/20Sr-nHA (C,F,I) after 14 days in culture; ((A–C) scale bar = 200 µm; (D–F) scale bar = 40 µm;
(G–I) scale bar = 8 µm).
Regarding the scaffold osteogenic potential, the ALP assay was performed up to 28 days. ALP is
an early marker of osteogenic differentiation and its expression decreases as bone tissue matures [74].
In Figure 10A the concentration of ALP normalized on the total protein content is shown. ALP activity
in all groups increased up to day 21, and decreased thereafter. However, and similarly to recent studies,
in the present work the inclusion of Sr-nHA in the polymeric matrix was not observed to sustain the
ALP activity in comparison to the control, and at each time point. With respect to the findings reported
by Zhou et al., where the expression of ALP increased for 2 weeks and then decreased, in our study
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ALP expression increased up to 3 weeks before decreasing [75]. This outcome could be related to
the type of cells used. In fact, according to Wilkesmann et al. U2OS cells have a significantly slow
osteogenic activity in comparison to primary human osteoblasts and primary mesenchymal stromal
cells, indicating the strong influence that cell types have on ALP expression [45].
Polymers 2020, 12, x 16 of 21 
 
 
Figure 10. (A) Normalized ALP activity of the PCL, PCL/10Sr-nHA and PCL/20Sr-nHA samples up 
to 28 days in culture with U2OS cells (data are presented as mean ± standard deviation. n = 6) and (B) 
optical microscopy images of cell-seeded scaffolds showing calcified nodules stained with Alizarin 
red after 0, 7, 14 and 28 days (scale bar = 400 μm). 
4. Conclusions 
To repair periodontal defects, advanced methodologies are required to manufacture scaffolds 
able to replicate the multi-layer architecture of the native tissue. In this study, we applied an emergent 
manufacturing technology able to produce a multi-layer composite scaffold varying simultaneously 
the composition and the geometry of the three former compartments, thus better mimicking the key 
features of the native hard periodontal tissue. The single step procedure allowed the achievement of 
excellent integrity among the different compartments guaranteeing mechanical stability of the whole 
structure. Overall, the results indicate that the additively manufactured scaffolds incorporated 
porosity levels and compressive properties within the range of dentoalveolar bone tissue. 
Furthermore, in vitro cell tests revealed a high U2OS cells viability and confirmed the important role 
of the inorganic phase (Sr-nHA) towards the mineralization process. 
Figure 10. (A) Normalized ALP activity of the PCL, PCL/10Sr-nHA and PCL/20Sr-nHA samples up
to 28 days in culture with U2OS cells (data are presented as mean ± standard deviation. n = 6) and
(B) optical microscopy images of cell-seeded scaffolds showing calcified nodules stained with Alizarin
red after 0, 7, 14 and 28 days (scale bar = 400 µm).
Mineralization potential was then assessed qualitatively by Alizarin red assay. Alizarin red,
an anthraquinone dye, has significant binding affinity to deposited calcium. Hence, it is normally used
to verify the presence of matrix mineralization, and as such, it is considered an early stage marker for
osteogenesis [76]. In our study, Alizarin red assay enabled us to prove the extent of mineralization
activity supported by 3D printed scaffolds. The stain color in all groups became darker by increasing
time intervals, suggesting that more calcium was deposited onto the scaffolds over time (Figure 10B).
There was a detectable difference in both the red staining color and presence of inorganic calcium
components over the surface of comp site-based samples; the inorga ic deposits resulted in being
bigge in size and more uniformly distributed in comparison to the trol. In agreement with recent
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literature, this observation demonstrates that greater mineralization was generated by the Sr-containing
scaffolds with respect to the monophasic PCL, indicating both PCL/10Sr-nHA and PCL/20Sr-nHA
samples as a promising platform for U2OS growth and osteogenesis [34,53,77].
4. Conclusions
To repair periodontal defects, advanced methodologies are required to manufacture scaffolds able
to replicate the multi-layer architecture of the native tissue. In this study, we applied an emergent
manufacturing technology able to produce a multi-layer composite scaffold varying simultaneously
the composition and the geometry of the three former compartments, thus better mimicking the key
features of the native hard periodontal tissue. The single step procedure allowed the achievement of
excellent integrity among the different compartments guaranteeing mechanical stability of the whole
structure. Overall, the results indicate that the additively manufactured scaffolds incorporated porosity
levels and compressive properties within the range of dentoalveolar bone tissue. Furthermore, in vitro
cell tests revealed a high U2OS cells viability and confirmed the important role of the inorganic phase
(Sr-nHA) towards the mineralization process.
In conclusion, the manufacturing process used revealed a highly versatile method to create
3D scaffolds with reproducible mechanical properties, and favorable biological performance,
avoiding drawbacks associated to poor integration of layers and cytotoxicity associated to solvent
residuals. Moving forward, the manufacturing strategy applied in this study may serve as a platform
for the development of more complex and patient-specific substitutes, allowing the inclusion of
additional biomaterials and bioactive cues that better match the overall architecture of the native
periodontal tissue, including the gingiva, and opening a new horizon in the tissue engineering field,
beyond dental applications.
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